BioCentury
ARTICLE | Financial News

Adventrx proposes follow-on

May 17, 2006 1:19 AM UTC

ANX proposed to sell 15.5 million shares in a follow-on underwritten by UBS; CIBC World Markets; RBC Capital Markets; and Fortis. If sold at Monday's close of $4.64, ANX would raise $71.9 million. The...